Takeover target Healthscope Ltd releases trading update

Healthscope Ltd (ASX:HSO) may reject another takeover approach.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

Shares in private hospital operator Healthscope Ltd (ASX: HSO) traded flat today after the takeover target provided a trading update where the group reaffirmed financial year 2019 guidance for hospital operating EBITDA growth of 10%.

For the quarter ending September 30 2019, Healthscope reported that it had achieved hospital operating EBITDA growth of 10.4%, compared to a 6.8% decline in the prior corresponding quarter.

The group also flagged that it opened its new Sydney's Northern Beaches hospital over the quarter that was built at an estimated cost of $840 million, with the company expecting to receive a "state capital payment of $400 million" relating to the build.

The group said the new hospital is expected to deliver "over $300 million in additional revenue and an EBITDA return on invested capital of at least 15%".

Healthscope is currently the subject of a $2.36 per share takeover offer from a consortium of capital market players including Australian Super and BGH, with the Healthscope board currently giving consideration to the offer.

As at October 31 the consortium seeking to takeover Healthscope owns 19.13% of the shares on issue.

In May 2018 it was also subject to a conditional $2.50 per share takeover to Canadian asset management and property development specialist Brookfield that Healthscope's board also rejected.

In 2015 and 2016 Healthscope's shares occasionally traded above $3 before a shock profit warning in October 2016 sent the share price into a nosedive. The problems were blamed on declining private healthcare affordability translating into lower hospital admissions.

Healthscope is largely focused on Australia unlike larger rival Ramsay Healthcare Ltd (ASX: RHC) that has continued to perform well in Australia, but struggled a little overseas in regions like the UK and France.

Healthscope's board maintains that the group is set to return to growth after labelling financial year 2018 a year of transition. In FY 2018 it paid a full year dividend of 6.7 cents, although it delivered basic earnings per share of just 4.4 cents. Total debt also stood at $1,946 million versus $156.8 million cash in hand.

Motley Fool contributor Yulia Mosaleva owns shares of Ramsay Health Care Limited. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Happy man standing in front of an oil rig.
Broker Notes

Why this sold-off ASX energy stock could rise 60%+

Bell Potter is tipping this stock as a buy following a sell-off this week.

Read more »

Cheerful businessman with a mining hat on the table sitting back with his arms behind his head while looking at his laptop's screen.
Share Market News

Vault Minerals: KoTH plant upgrade commissioning kicks off

Vault Minerals has started commissioning the first stage of its major King of the Hills plant upgrade, keeping the project…

Read more »

A woman sits in a quiet home nook with her laptop computer and a notepad and pen on the table next to her as she smiles at information on the screen.
Share Market News

Sims Group earnings: SLS now core to growth

Sims Group’s SLS business now accounts for 40% of earnings and is driving strong growth with hyperscaler partners.

Read more »

a man sits on his sofa loong at his phone and raises a fist to the air in happy celebration.
Share Market News

Infratil lifts CDC outlook and FY27 earnings guidance

Infratil lifted its CDC earnings guidance and expanded its data centre operations in response to robust sector demand.

Read more »

A businesswoman on the phone is shocked as she looks at her watch, she's running out of time.
Share Market News

How long will it take for the ASX 200 to recover? Expert

A recent Betashares report explored how long similar falls in the past have taken to recover.

Read more »

Young man with a laptop in hand watching stocks and trends on a digital chart.
Share Market News

5 things to watch on the ASX 200 on Thursday

Here's what you need to know ahead of today's session.

Read more »

Two smiling work colleagues discuss an investment at their office.
Broker Notes

Buy, hold, sell: NAB, Pro Medicus, and Telstra shares

Let's see what analysts are saying about these big names.

Read more »

A group of happy young people watching sport on a laptop celebrate.
Share Gainers

Here are the top 10 ASX 200 shares today

It was an exceptional session for investors today.

Read more »